Diag Nose
2 known investors
Diag-Nose.io develops AI-powered precision diagnostics for respiratory diseases using nasal microsampling, proteomics, and machine learning algorithms. The platform targets patients and clinicians to enable personalized treatment selection and improve outcomes for chronic respiratory conditions like asthma, COPD, and chronic sinusitis.